/PRNewswire/ Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically.
Form N-CSR BlackRock Capital Apprec For: May 31 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
CAMBRIDGE, Mass., Aug. 1, 2023 /PRNewswire/ Nuvalent, Inc. , a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in.
Nuvalent, Inc (NASDAQ:NUVL) Insider Sells $110,800 25 in Stock kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Nuvalent, Inc. (NASDAQ:NUVL – Get Free Report) insider Darlene Noci sold 4,559 shares of the company’s stock in a transaction dated Wednesday, July 19th. The shares were sold at an average price of $45.04, for a total transaction of $205,337.36. The sale was disclosed in a filing with the SEC, which is available at the […]